diaendoСахарный диабетDiabetes mellitus2072-03512072-0378Endocrinology research centre10.14341/DM2013444-48diaendo-6258Research ArticleЭкспериментальная диабетологияExperimental DiabetologyМорфологическая характеристика эпителия слизистой оболочки бронхиального дерева при стрептозотоциновом диабетеMorphology of bronchial epithelium in rodent streptozotocin-induced diabetes mellitusПивовароваОксана АнатольевнаPivovarovaOksana Anatolyevna

кандидат медицинских наук, доцент кафедры внутренней медицины

MD, PhD, Assintant Professor in Internal Medicine Department

aksiniyalosk@mail.ruМанковскийБорис НикитичMankovskyBoris Nikitich

доктор медицинских наук, профессор, член-корреспондент НАМН Украины, заведущий кафедрой диабетологии

MD, PhD, Professor, Fellow of Ukraine National Academy of Medical Sciences, Head of Endocrinology Department

aksiniyalosk@mail.ruГУ Луганский государственный медицинский университет, ЛуганскУкраинаState Establishment "Lugansk State Medical University", LuganskUkraineНациональная медицинская академия последипломного образования им. П.Л. Шупика, КиевУкраинаP.L.Shupik National Medical Academy of post-graduate education, KievUkraine2013181220131644448Copyright © Пивоварова О.А., Манковский Б.Н., 20132013Пивоварова О.А., Манковский Б.Н.Pivovarova O.A., Mankovsky B.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.dia-endojournals.ru/jour/article/view/6258стрептозотоциновый диабетбронхиальное деревоморфометрияstreptozotocin-induced diabetesbronchimorphologyReferencesVila-Corcoles A, Ochoa-Gondar O. Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview. Expert Review of Vaccines. 2012;11(2):221–236.Vila-Corcoles A, Ochoa-Gondar O. Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview. Expert Review of Vaccines. 2012;11(2):221–236.DOI: 10.1586/erv.11.176DOI: 10.1586/erv.11.176Kheradmand F, Shan M, Xu C, Corry DB. Autoimmunity in chronic obstructive pulmonary disease: clinical and experimental evidence. Expert Review of Clinical Immunology. 2012;8(3):285–292.Kheradmand F, Shan M, Xu C, Corry DB. Autoimmunity in chronic obstructive pulmonary disease: clinical and experimental evidence. Expert Review of Clinical Immunology. 2012;8(3):285–292.DOI: 10.1586/eci.12.7DOI: 10.1586/eci.12.7Mukhopadhyay S, Hoidal JR, Mukherjee TK. Role of TNF-alpha in pulmonary pathophysiology. Respiratory research. 2006;7:125–130.Mukhopadhyay S, Hoidal JR, Mukherjee TK. Role of TNF-alpha in pulmonary pathophysiology. Respiratory research. 2006;7:125–130.Parker C,Thavagnanam ST, Skibinski G,Heaney LG, Shields MD.Mechanisms of lung infection in the community and hospital setting:S86 effects of exposure to IL-13, IL-31 and an IL-13/31 combination on mucociliary differentiation of bronchial epithelial cells. Thorax.2010;65(Suppl 4):A40.Parker C,Thavagnanam ST, Skibinski G,Heaney LG, Shields MD.Mechanisms of lung infection in the community and hospital setting:S86 effects of exposure to IL-13, IL-31 and an IL-13/31 combination on mucociliary differentiation of bronchial epithelial cells. Thorax.2010;65(Suppl 4):A40.doi: 10.1136/thx.2010.150938.37doi: 10.1136/thx.2010.150938.37Pasteur MC, Bilton D,Hill AT. British thoracicsociety guideline for non-CFbronchiectasis.Thorax.2010;65(Suppl 1):i1–i58.Pasteur MC, Bilton D,Hill AT. British thoracicsociety guideline for non-CFbronchiectasis.Thorax.2010;65(Suppl 1):i1–i58.DOI: 10.1136/thx.2010.136119DOI: 10.1136/thx.2010.136119Lee P, Khoo KL. A review of current bronchoscopic interventions for obstructive airway diseases. Therapeutic Advances in Respiratory Disease. 2012;6(5):297–307.Lee P, Khoo KL. A review of current bronchoscopic interventions for obstructive airway diseases. Therapeutic Advances in Respiratory Disease. 2012;6(5):297–307.DOI: 10.1177/1753465812455448DOI: 10.1177/1753465812455448Lommatzsch SE, Martin RJ.Importance of fiberoptic bronchoscopy in identifying asthma phenotypes to direct personalized therapy. Current opinion in pulmonary medicine. 2013;19(1):42–48.Lommatzsch SE, Martin RJ.Importance of fiberoptic bronchoscopy in identifying asthma phenotypes to direct personalized therapy. Current opinion in pulmonary medicine. 2013;19(1):42–48.DOI: 10.1097/MCP.0b013e32835a5bdcDOI: 10.1097/MCP.0b013e32835a5bdcMirrakhimov AE. Chronic obstructive pulmonary disease and glucose metabolism. Cardiovascular Diabetology. 2012;11:132.Mirrakhimov AE. Chronic obstructive pulmonary disease and glucose metabolism. Cardiovascular Diabetology. 2012;11:132.DOI: 10.1186/1475-2840-11-132DOI: 10.1186/1475-2840-11-132ClayAS, BehniaM, BrownKK. Mitochondrial disease: A pulmonary and critical-care medicine perspective. Chest. 2001;120(2):634–648.ClayAS, BehniaM, BrownKK. Mitochondrial disease: A pulmonary and critical-care medicine perspective. Chest. 2001;120(2):634–648.DOI: 10.1378/chest.120.2.634DOI: 10.1378/chest.120.2.634Maniscalco WM, Watkins RH, O'Reilly MA, Shea CP. Increased epithelial cell proliferation in very premature baboons with chronic lung disease. American Journal of Physiology – Lung Cellular and Molecular Physiology. 2002;283(5):L991–L1001.Maniscalco WM, Watkins RH, O'Reilly MA, Shea CP. Increased epithelial cell proliferation in very premature baboons with chronic lung disease. American Journal of Physiology – Lung Cellular and Molecular Physiology. 2002;283(5):L991–L1001.DOI: 10.1152/ajplung.00050.2002DOI: 10.1152/ajplung.00050.2002Skjøt-Arkil H, Clausen RE, Nguyen QH, Wang Y, Zheng Q, Martinez FJ, et al. Measurement of MMP-9 and -12 degraded elastin (ELM) provides unique information on lung tissue degradation. BMC Pulmonary Medicine. 2012;12:34.Skjøt-Arkil H, Clausen RE, Nguyen QH, Wang Y, Zheng Q, Martinez FJ, et al. Measurement of MMP-9 and -12 degraded elastin (ELM) provides unique information on lung tissue degradation. BMC Pulmonary Medicine. 2012;12:34.DOI: 10.1186/1471-2466-12-34DOI: 10.1186/1471-2466-12-34Tam A, Wadsworth S, Dorscheid D, Man SFP, Sin DD. The airway epithelium: more than just a structural barrier. Therapeutic Advances in Respiratory Disease. 2011;5(4):255–273.Tam A, Wadsworth S, Dorscheid D, Man SFP, Sin DD. The airway epithelium: more than just a structural barrier. Therapeutic Advances in Respiratory Disease. 2011;5(4):255–273.DOI: 10.1177/1753465810396539DOI: 10.1177/1753465810396539Ходзицкая ВК. Нарушение и коррекция мукоцилиарного клиренса при заболеваниях дыхательных путей. Болезни и антибиотики. 2010;1(3):5–12. [Khodzitskaya VK. Narushenie i korrektsiya mukotsiliarnogo klirensa pri zabolevaniyakh dykhatel'nykh putey. Bolezni i antibiotiki. 2010;1(3):5–12].Ходзицкая ВК. Нарушение и коррекция мукоцилиарного клиренса при заболеваниях дыхательных путей. Болезни и антибиотики. 2010;1(3):5–12. [Khodzitskaya VK. Narushenie i korrektsiya mukotsiliarnogo klirensa pri zabolevaniyakh dykhatel'nykh putey. Bolezni i antibiotiki. 2010;1(3):5–12].Wood AM, Stockley RA. Editorial: Unifying the genetics, co-morbidities and management of COPD. Therapeutic Advances in Respiratory Disease. 2008;2(3):113–117.Wood AM, Stockley RA. Editorial: Unifying the genetics, co-morbidities and management of COPD. Therapeutic Advances in Respiratory Disease. 2008;2(3):113–117.DOI: 10.1177/1753465808092282DOI: 10.1177/1753465808092282Березин АЕ. Биологические прогностические факторы риска у пациентов с внебольничной пневмонией. Клиническое значение, ожидания и перспективы. Український медичний часопис. 2010;77(3):81–87. [Berezin AE. Biologicheskie prognosticheskie faktory riska u patsientov s vnebol'nichnoy pnevmoniey. Klinicheskoe znachenie, ozhidaniya i perspektivy. Ukraїns'kiy medichniyБерезин АЕ. Биологические прогностические факторы риска у пациентов с внебольничной пневмонией. Клиническое значение, ожидания и перспективы. Український медичний часопис. 2010;77(3):81–87. [Berezin AE. Biologicheskie prognosticheskie faktory riska u patsientov s vnebol'nichnoy pnevmoniey. Klinicheskoe znachenie, ozhidaniya i perspektivy. Ukraїns'kiy medichniy

The authors declare that there are no conflicts of interest present.